← Back to the fund page Use your browser's print dialog and choose “Save as PDF”. A4.
InvestVerdict

DSP Healthcare Fund

Regular Plan · Growth · Sectoral / Thematic · Scheme code 145456

NAV₹44.7550as on 29 Oct 2026
Fund houseDSP Mutual Fund
CategorySectoral / Thematic
Plan & optionRegular · Growth
History7.7 years

Returns (%)

 1M3M6M1Y3Y5Y7Y10YLaunch
This scheme 3.6612.7120.73 17.6821.2514.81 24.86—21.73
Nifty 500
benchmark		 0.874.312.15 5.2012.4911.41 ——15.49
Sectoral / Thematic
category median		 ——— -6.5811.548.85 —12.68—

Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published NAV history for this scheme.

Risk

 VolatilitySharpeSortinoBetaAlphaMax fallR²
This scheme 14.9% 0.99 1.75 0.69 10.59% -22.1% 49.81
Nifty 500
benchmark		 15.2%0.39 0.58—— -37.3%—

Risk-free rate 6.5%. Beta, alpha and R² are regressed on the 36 months this scheme and its benchmark share.

Growth of ₹100 since launch

672073474872020202220242026InvestVerdict

Drawdown from peak (%)

0%-8%-16%-24%2020202220242026

Every one-year period it has lived through

WindowsWorstMedianBestPeriods that lost money
1,642 -15.2% 19.8% 94.1% 22%

Every one-year holding period in this scheme's history, not just the last one — the spread a real investor would have met depending only on when they started.

How it behaves against its benchmark

Up captureDown captureCorrelation Tracking errorInformation ratioTreynor
105% 55% 0.71 11.5% 0.76 21.25

Up capture is how much of the benchmark's gain this scheme kept in the months the benchmark rose; down capture, how much of its fall it took. Below 100 on the down side and above it on the up side is the combination every fund is trying for and few reach. Measured over the 36 months this scheme and Nifty 500 share.

InvestVerdict

DSP Healthcare Fund

Regular Plan · Growth

Allocation

By asset

Equity83.95%
Foreign Securities9.31%
Cash & Equivalents6.74%

By market cap

Large Cap24.86%
Mid Cap14.16%
Small Cap42.73%
Unclassified11.51%

Concentration

Number of stocks32
Top 5 stocks35.42%
Top 10 stocks59.35%
Top 20 stocks83.47%
Lines in the filing34
Largest holding8.13%
Largest sectorPharmaceuticals & Biotechnology 65.75%
Effective stocks22.7
Sectors held5
Cash6.74%

Effective stocks is what the concentration works out to: a fund holding 32 names but most of its money in a few behaves like a fund of 23. Cash includes repo and TREPS, which every fund parks money in overnight.

Sector split

Pharmaceuticals & Biotechnology — 65.8%Healthcare Services — 17.8%Healthcare Equipment & Supplies — 7.6%Cash & Equivalents — 6.7%Other — 2.1%Pharmaceuticals & Biotech…65.8%Healthcare Services17.8%Healthcare Equipment & Su…7.6%Cash & Equivalents6.7%Other2.1%
Pharmaceuticals & Biotechnology65.75%
Healthcare Services17.84%
Healthcare Equipment & Supplies7.55%
Cash & Equivalents6.74%
Foreign Security1.10%
Insurance1.02%
InvestVerdict

DSP Healthcare Fund

Regular Plan · Growth · holdings

Top 30 holdings

#CompanySectorShares held Value
₹ cr		% of fund
1 IPCA Laboratories Limited Pharmaceuticals & Biotechnology 1,582,807 305 8.13%
2 Sun Pharmaceutical Industries Limited Pharmaceuticals & Biotechnology 1,535,592 279 7.44%
3 Cipla Limited Pharmaceuticals & Biotechnology 2,001,379 269 7.18%
4 TREPS / Reverse Repo Investments Unclassified — 255 6.81%
5 Sai Life Sciences Limited Pharmaceuticals & Biotechnology 1,602,712 244 6.52%
6 Gland Pharma Limited Pharmaceuticals & Biotechnology 795,267 231 6.15%
7 Apollo Hospitals Enterprise Limited Healthcare Services 278,729 228 6.07%
8 Globus Medical Inc Healthcare Equipment & Supplies 268,800 193 5.15%
9 Alkem Laboratories Limited Pharmaceuticals & Biotechnology 344,654 178 4.75%
10 Divi's Laboratories Limited Pharmaceuticals & Biotechnology 168,223 156 4.17%
11 Cohance Lifesciences Limited Pharmaceuticals & Biotechnology 3,202,999 142 3.79%
12 Alembic Pharmaceuticals Limited Pharmaceuticals & Biotechnology 1,442,516 119 3.18%
13 Kovai Medical Center And Hospital Limited Healthcare Services 176,815 106 2.83%
14 Pfizer Limited Pharmaceuticals & Biotechnology 263,627 102 2.72%
15 Concord Biotech Limited Pharmaceuticals & Biotechnology 735,820 101 2.70%
16 Vijaya Diagnostic Centre Limited Healthcare Services 615,708 89 2.36%
17 Procter & Gamble Health Limited Pharmaceuticals & Biotechnology 159,288 89 2.36%
18 Indoco Remedies Limited Pharmaceuticals & Biotechnology 3,245,682 85 2.26%
19 Intuitive Surgical Inc Healthcare Equipment & Supplies 18,768 73 1.95%
20 Thyrocare Technologies Limited Healthcare Services 1,341,127 72 1.91%
21 Manipal Health Enterprises Limited Healthcare Services 980,058 69 1.85%
22 Unichem Laboratories Limited Pharmaceuticals & Biotechnology 1,128,668 62 1.64%
23 Syngene International Limited Healthcare Services 1,385,126 51 1.35%
24 Nephrocare Health Services Limited Healthcare Services 634,983 42 1.12%
25 Global X Funds - Global X Genomics & Biotechnology ETF Foreign Security 61,250 41 1.10%
26 ICICI Lombard General Insurance Co Limited Insurance 241,413 38 1.02%
27 Aarti Drugs Limited Pharmaceuticals & Biotechnology 852,155 37 0.98%
28 Abbott Laboratories Pharmaceuticals & Biotechnology 31,600 30 0.80%
29 Eris Lifesciences Limited Pharmaceuticals & Biotechnology 225,856 27 0.72%
30 Jupiter Life Line Hospitals Limited Healthcare Services 516,535 13 0.35%
InvestVerdict

DSP Healthcare Fund

Regular Plan · Growth · where the money sits

What the manager did last month

Between the filings of 30 Jun 2026 and 31 Jul 2026. A position grows because the manager bought or because the price rose; only the share count separates them.

BoughtSoldNew positionsSold out ofPrice move of holdings
₹120 cr ₹0 cr 4 3 +1.95%
StockShares tradedShares PriceValue
₹ cr
New position
Manipal Health Enterprises Ltd 1,859,425 entered — 110
Divi's Laboratories Ltd 105,248 entered — 84.8
Eris Lifesciences Ltd 225,856 entered — 30.6
Jupiter Life Line Hospitals Ltd 516,535 entered — 17.1
Added to
Alkem Laboratories Ltd 129,071 +78.3% +3.3% 74.2
Apollo Hospitals Enterprise Ltd 40,665 +20.9% +3.2% 36.4
Syngene International Ltd 142,391 +12.9% -12.2% 5.5
Pfizer Ltd 5,034 +2.5% +8.7% 2.4
Cohance Lifesciences Ltd 23,118 +0.7% -6.8% 1.0
Unichem Laboratories Ltd 13,881 +1.3% +11.2% 0.7
Sold out of
Illumina Inc 160,400 exited — 267
Jupiter Life Line Hospitals Limited 94,117 exited — 13.4
Emcure Pharmaceuticals Limited 69,966 exited — 12.9
Not equityPrevious filingThis filingChange
Cash, repo and TREPS ₹0 cr ₹0 cr +₹0 cr

The list above is stocks and fund units. Treasury bills, repo and money-market lines roll over every month by design — they are not decisions, so they are totalled here rather than listed as activity.

A ₹10,000 monthly SIP over five years

InvestedValueGainXIRR
₹600,000 ₹970,642 ₹370,642 19.34%

XIRR, not CAGR — a SIP's money arrives over sixty months, so each instalment has been invested for a different length of time.

Not investment advice. InvestVerdict is not a SEBI-registered Investment Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past returns do not predict future ones. Generated 1 Nov 2026.